Related Experiment Videos
Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase
1Institut für Molekulare Virologie, GSF-Forschungszentrum für Unwelt und Gesundheit GmbH, Oberschleissheim, FRG.
FEBS Letters
|August 28, 1995
Summary
Modified vaccinia virus Ankara (MVA) serves as a safe vector for gene expression. A recombinant MVA expressing T7 RNA polymerase enables efficient gene synthesis in mammalian cells without viral replication.
Area of Science:
- Virology
- Molecular Biology
- Biotechnology
Background:
- Modified vaccinia virus Ankara (MVA) is a highly attenuated vaccinia virus strain with restricted host range, unable to replicate in human and most mammalian cells.
- Recombinant MVA viruses are safe and efficient expression vectors due to unimpaired viral gene expression in non-permissive cells.
Purpose of the Study:
- To construct a recombinant MVA expressing bacteriophage T7 RNA polymerase.
- To evaluate its utility for transient gene expression under a T7 promoter in mammalian cells.
Main Methods:
- Construction of a recombinant MVA expressing T7 RNA polymerase (MVA-T7pol).
- Testing MVA-T7pol for transient expression of the chloramphenicol acetyltransferase (CAT) reporter gene in mammalian cells.
- Comparison of enzyme activities with a replication-competent vaccinia-T7pol recombinant virus.
Main Results:
- MVA-T7pol facilitated efficient synthesis of the recombinant CAT enzyme in mammalian cells.
- Enzyme activities induced by MVA-T7pol were comparable to those from a replication-competent vaccinia-T7pol virus.
- Demonstrated successful T7 RNA polymerase-specific gene expression despite MVA's host restriction.
Conclusions:
- MVA-T7pol is a novel vaccinia vector for T7 RNA polymerase-specific gene expression.
- This vector enables efficient recombinant gene expression in mammalian cells without productive vaccinia virus replication.
- Highlights the safety and efficacy of MVA-based vectors for gene expression applications.